Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Atypical granular cell tumor occurring in an individual with Noonan syndrome treated with growth hormone.

Moos D, Droitcourt C, Rancherevince D, Marec Berard P, Skowron F.

Pediatr Dermatol. 2012 Sep-Oct;29(5):665-6. doi: 10.1111/j.1525-1470.2011.01641.x. Epub 2012 Feb 14.

PMID:
22329457
2.

Multiple granular cell tumors in a child with Noonan syndrome.

Ramaswamy PV, Storm CA, Filiano JJ, Dinulos JG.

Pediatr Dermatol. 2010 Mar-Apr;27(2):209-11. doi: 10.1111/j.1525-1470.2010.01111.x.

PMID:
20537083
3.

Granular cell tumor of the scrotum in a child with Noonan syndrome.

Sidwell RU, Rouse P, Owen RA, Green JS.

Pediatr Dermatol. 2008 May-Jun;25(3):341-3. doi: 10.1111/j.1525-1470.2008.00678.x.

PMID:
18577039
4.

Response to growth hormone in short children with Noonan syndrome: correlation to genotype.

Binder G.

Horm Res. 2009 Dec;72 Suppl 2:52-6. doi: 10.1159/000243781. Epub 2009 Dec 22.

PMID:
20029239
5.

Growth hormone therapy in Noonan syndrome: growth response and characteristics.

Westphal O.

Horm Res. 2009 Dec;72 Suppl 2:41-5. doi: 10.1159/000243778. Epub 2009 Dec 22.

PMID:
20029236
6.

Occurrence of DNET and other brain tumors in Noonan syndrome warrants caution with growth hormone therapy.

McWilliams GD, SantaCruz K, Hart B, Clericuzio C.

Am J Med Genet A. 2016 Jan;170A(1):195-201. doi: 10.1002/ajmg.a.37379. Epub 2015 Sep 17. Review.

PMID:
26377682
7.

[Genetic identification of a case of Noonan syndrome and treatment with growth hormone].

Pi G, Zúñiga A, Gastaldo E, Ortiz M.

Med Clin (Barc). 2014 Apr 22;142(8):378-9. doi: 10.1016/j.medcli.2013.06.019. Epub 2013 Sep 20. Spanish. No abstract available.

PMID:
24054841
8.

Noonan syndrome: growth to growth hormone - the experience of observational studies.

Ranke MB.

Horm Res. 2009 Dec;72 Suppl 2:36-40. doi: 10.1159/000243777. Epub 2009 Dec 22.

PMID:
20029235
9.

Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11.

Noordam C, Peer PG, Francois I, De Schepper J, van den Burgt I, Otten BJ.

Eur J Endocrinol. 2008 Sep;159(3):203-8. doi: 10.1530/EJE-08-0413. Epub 2008 Jun 18.

PMID:
18562489
10.

Multiple subcutaneous granular-cell tumours in a patient with Noonan syndrome.

Lohmann DR, Gillessen-Kaesbach G.

Clin Dysmorphol. 2000 Oct;9(4):301-2.

PMID:
11045593
11.

GH therapy in Noonan syndrome: Review of final height data.

Dahlgren J.

Horm Res. 2009 Dec;72 Suppl 2:46-8. doi: 10.1159/000243779. Epub 2009 Dec 22. Review.

PMID:
20029237
12.

Growth hormone and the heart in Noonan syndrome.

Noordam C.

Horm Res. 2009 Dec;72 Suppl 2:49-51. doi: 10.1159/000243780. Epub 2009 Dec 22. Review.

PMID:
20029238
13.

Response to growth hormone therapy in children with Noonan syndrome: correlation with or without PTPN11 gene mutation.

Choi JH, Lee BH, Jung CW, Kim YM, Jin HY, Kim JM, Kim GH, Hwang JS, Yang SW, Lee J, Yoo HW.

Horm Res Paediatr. 2012;77(6):388-93.

14.

[Noonan syndrome: from phenotype to growth hormone therapy].

Malaquias AC, Ferreira LV, Souza SC, Arnhold IJ, Mendonça BB, Jorge AA.

Arq Bras Endocrinol Metabol. 2008 Jul;52(5):800-8. Review. Portuguese.

15.

Noonan syndrome, the Ras-MAPK signalling pathway and short stature.

Binder G.

Horm Res. 2009 Apr;71 Suppl 2:64-70. doi: 10.1159/000192439. Epub 2009 Apr 29. Review.

PMID:
19407499
16.

Co-occurring PTPN11 and SOS1 gene mutations in Noonan syndrome: does this predict a more severe phenotype?

Brasil AS, Malaquias AC, Wanderley LT, Kim CA, Krieger JE, Jorge AA, Pereira AC, Bertola DR.

Arq Bras Endocrinol Metabol. 2010 Nov;54(8):717-22.

17.

[Noonan syndrome].

Ogata T.

Nihon Rinsho. 2006 Jun 28;Suppl 2:505-10. Review. Japanese. No abstract available.

PMID:
16817452
18.

[The Noonan syndrome from a pediatric perspective].

Noordam C, Thoonen G, van der Burgt CJ.

Ned Tijdschr Geneeskd. 2003 Apr 5;147(14):644-8. Review. Dutch.

PMID:
12712646
19.

[Phenotype variability in Noonan syndrome patients with and without PTPN11 mutation].

Ferreira LV, Souza SA, Montenegro LR, Arnhold IJ, Pasqualini T, Heinrich JJ, Keselman AC, Mendonça BB, Jorge AA.

Arq Bras Endocrinol Metabol. 2007 Apr;51(3):450-6. Portuguese.

20.

[SOS1 mutation: a new cause of Noonan syndrome].

Serrano-Martín MM, Martínez-Aedo MJ, Tartaglia M, López-Siguero JP.

An Pediatr (Barc). 2008 Apr;68(4):365-8. Spanish.

Supplemental Content

Support Center